GlassScriptPhysician profile
Brian J Mason
NPI 1346248028
$33,014.88
in general payments reported to CMS, 2019-2025
10 companies · $32K in 2025
The $32K reported for 2025 was more than what 95% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $12.17 · 2021: $247 · 2022: $322 · 2023: $116 · 2024: $101 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,360.00 |
| Food and Beverage | $580.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aidoc Medical LTD | $31,360.00 | 2025 | Briefcase |
| Stryker Corporation | $465.08 | 2019-2021 | |
| Spinal Elements, INC. | $331.92 | 2025 | |
| Medtronic, INC. | $307.34 | 2022-2024 | Pipeline |
| Penumbra, INC. | $245.23 | 2019 | |
| Microvention, INC. | $180.63 | 2022-2025 | Sofia 5f-125cm Str |
| Balt USA, LLC | $82.43 | 2022 | |
| Ge Healthcare | $24.90 | 2019-2020 | |
| Abbott Laboratories | $17.35 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$523,934.83 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.